Gynuity envisions a world in which each individual has access to safe and effective reproductive and maternal health care—delivered where, when, and how needed.
It is our mission to develop scientific, clinical and programmatic evidence in reproductive and maternal health and to advocate for its use, assuring that each individual benefits from the fruits of medical science and technology. We do this on a global scale through research, strategic partnerships, and communications for impact.
Gynuity listens to women, providers and policymakers, and works with them to create services that are safe, high quality, and person-centered. Through conversations and active collaborations, we use research to fill evidence gaps for new models of care, influence change, and advocate for improvements in policy and practice.
Our research demonstrates that simple, safe, and effective reproductive and maternal health technologies transform lives and improve outcomes for women and girls.
Through speaking, convening partners, and publishing our research, we create the synergies that trigger change in policy and practice.
Strategic communications increase the impact of our research and programmatic findings.
Using telemedicine to reduce the cost of medical abortion to patients and extend the reach of providers to rural areas and across state lines
Mifepristone and sublingual misoprostol versus sublingual misoprostol alone for missed abortion: Results of a randomized placebo-controlled trial
Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee
Gynuity is providing a safe and effective way for women to access medical abortion using telemedicine.Visit the TelAbortion Website
Gynuity's image bank offers illustrations that can help articulate concepts across audiences. Available for download.View the Image Bank
Gynuity has been at the forefront of global women’s health since 2003.See our Achievements